In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
Intravenous injection of anti-asialo GM1, which has been shown to eliminate natural killer (NK) activity in vitro in the presence of complement, completely abolished NK activity against lymphoma cell line (YAC-1) in spleen cells from athymic nude mice as well as from conventional mice. An immunofluorescence study revealed a decreased number of asialo GM1 positive cells in the spleens of mice injected with anti-asialo GM1 than in those of mice injected with normal rabbit serum. In the nude mice with reduced NK activity, incidence of tumor take and the growth were enhanced when syngeneic (RL male-1), and allogeneic (YAC-1) tumors and human tumors were transplanted subcutaneously. These results strongly suggest that NK cells play an important role in transplanted-tumor growth in vivo.
D000818:Animals; D000906:Antibodies; D002471:Cell Transformation, Neoplastic; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D005677:G(M1) Ganglioside / Q000276:immunology*; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007264:Inguinal Canal / Q000473:pathology; D007694:Killer Cells, Natural / Q000276:immunology*; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude / Q000502:physiology*; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D011817:Rabbits; D013274:Stomach Neoplasms / Q000276:immunology
D000906:Antibodies; D005732:Gangliosides; D005677:G(M1) Ganglioside